<DOC>
	<DOCNO>NCT02572960</DOCNO>
	<brief_summary>To investigate possible physiologic interaction adrenal- parathyroid gland patient secondary hyperparathyroidism .</brief_summary>
	<brief_title>Physiologic Interactions Between Adrenal- Parathyroid Glands</brief_title>
	<detailed_description>In primary hyperparathyroidism , chronic-elevated PTH level seem stimulate renin-angiotensin-aldosterone system ( RAAS ) may explain increased risk cardiovascular disease . In addition increase PTH level , vitamin D show inhibit RAAS . However , possible physiologic interaction need investigation . The purpose study investigate change RAAS otherwise healthy postmenopausal woman secondary hyperparathyroidism due vitamin D deficiency p-PTH normalized . Furthermore , evaluate whether angiotensin 2 receptor blocker lower PTH patient secondary hyperparathyroidism .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Secondary hyperparathyroidism due Vitamin D deficiency Cardiovascular disease Renal failure Liver failure Treatment antihypertensive medication diuretic Treatment lithium , NSAID glucocorticoids Calcium supplement 500 mg per day Vitamin D supplement 25 microgram per day Medical treatment osteoporosis Systolic blood pressure 120 mmHg Hypercalcaemia ( 1,33mmol/L ) Use solarium plan trip country , might increase endogenous vitamin D synthesis Allergic reaction ACEi ARBs .</criteria>
	<gender>Female</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>